ADVERTISEMENT

New non-hormonal therapy relieves menopausal hot flashes

Miriam Davis   |   Clinical Summary   |   17 March 2023
ADVERTISEMENT

Takeaway

  • A new non-hormonal therapy, fezolinetant, reduces the frequency and severity of moderate-to-severe vasomotor symptoms associated with menopause (also called hot flashes or hot flushes) in the phase 3 SKYLIGHT 1 trial.
  • The drug also improves quality of life.
  • Findings by an international team were reported in The Lancet ....

          

March Challenge

Ends in 4d 19h
left
right

Topic Challenges

left
right